Literature DB >> 12006621

Calmodulin-containing substructures of the centrosomal matrix released by microtubule perturbation.

Nicoleta Moisoi1, Muriel Erent, Sheena Whyte, Stephen Martin, Peter M Bayley.   

Abstract

Calmodulin redistribution in MDCK and HeLa cells subjected to microtubule perturbations by antimitotic drugs was followed using a calmodulin-EGFP fusion protein that preserves the Ca(2+) affinity, target binding and activation properties of native calmodulin. CaM-EGFP targeting to spindle structures in normal cell division and upon spindle microtubule disruption allows evaluation of the dynamic redistribution of calmodulin in cell division. Under progressive treatment of stably transfected mammalian cells with nocodazole or vinblastine, the centrosomal matrix at the mitotic poles subdivides into numerous small 'star-like' structures, with the calmodulin concentrated centrally, and partially distinct from the reduced microtubule mass to which kinetochores and chromosomes are attached. Prolonged vinblastine treatment causes the release of localised calmodulin into a uniform cytoplasmic distribution, and tubulin paracrystal formation. By contrast, paclitaxel treatment of metaphase cells apparently causes limited disassembly of the pericentriolar material into a number of multipolar 'ring-like' structures containing calmodulin, each one having multiple attached microtubules terminating in the partially disordered kinetochore/chromosome complex. Thus drugs with opposite effects in either destabilising or stabilising mitotic microtubules cause subdivision of the centrosomal matrix into two distinctive calmodulin-containing structures, namely small punctate 'stars' or larger polar 'rings' respectively. The 'star-like' structures may represent an integral subcomponent for the attachment of kinetochore microtubules to the metaphase centrosome complex. The results imply that microtubules have a role in stabilising the structure of the pericentriolar matrix, involving interaction, either direct or indirect, with one or more proteins that are targets for binding of calmodulin. Possible candidates include the pericentriolar matrix-associated coiled-coil proteins containing calmodulin-binding motifs, such as myosin V, kendrin (PCNT2) and AKAP450.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006621     DOI: 10.1242/jcs.115.11.2367

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  6 in total

1.  Dissociating the centrosomal matrix protein AKAP450 from centrioles impairs centriole duplication and cell cycle progression.

Authors:  Guy Keryer; Oliwia Witczak; Annie Delouvée; Wolfram A Kemmner; Danielle Rouillard; Kjetil Tasken; Michel Bornens
Journal:  Mol Biol Cell       Date:  2003-03-07       Impact factor: 4.138

2.  Fluorescent vinblastine probes for live cell imaging.

Authors:  Labros G Meimetis; Randy J Giedt; Hannes Mikula; Jonathan C Carlson; Rainer H Kohler; David B Pirovich; Ralph Weissleder
Journal:  Chem Commun (Camb)       Date:  2016-08-02       Impact factor: 6.222

3.  Genome-wide identification of Arabidopsis coiled-coil proteins and establishment of the ARABI-COIL database.

Authors:  Annkatrin Rose; Sankaraganesh Manikantan; Shannon J Schraegle; Michael A Maloy; Eric A Stahlberg; Iris Meier
Journal:  Plant Physiol       Date:  2004-03       Impact factor: 8.340

4.  Gene variants associated with ischemic stroke: the cardiovascular health study.

Authors:  May M Luke; Ellen S O'Meara; Charles M Rowland; Dov Shiffman; Lance A Bare; Andre R Arellano; W T Longstreth; Thomas Lumley; Kenneth Rice; Russell P Tracy; James J Devlin; Bruce M Psaty
Journal:  Stroke       Date:  2008-11-20       Impact factor: 7.914

5.  Association of CALM1 rs3179089 Polymorphism with Ischemic Stroke in Chinese Han Population.

Authors:  Lian Gu; Jingyan Huang; Jinhong Li; Siyun Huang; Minhua Li; Lin Gong; Tongshun Li; Li Su
Journal:  Neuromolecular Med       Date:  2018-04-30       Impact factor: 3.843

6.  Loss of PINK1 enhances neurodegeneration in a mouse model of Parkinson's disease triggered by mitochondrial stress.

Authors:  Nicoleta Moisoi; Valentina Fedele; Jennifer Edwards; L Miguel Martins
Journal:  Neuropharmacology       Date:  2013-10-23       Impact factor: 5.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.